Condition: Myofascial Pain Dysfunction Syndrome · Sponsor: Cairo University
Two groups of patients diagnosed with Myofascial Pain Dysfunction Syndrome (MPDS) will be included in this study. One group will receive trigger point injections of lidocaine alone. The other group will receive trigger point injections of lidocaine combined with magnesium sulfate. The study aims to compare the effectiveness of both treatments in reducing pain and improving muscle function. Patients will be assessed using a pain scale (VAS) and surface electromyography (sEMG) to measure muscle activity.
This description comes directly from the study's public registry record.
Maii E Abdelazeem, BSc · +20 1013988933 · Maii.emad@dentistry.cu.edu.eg
Khaled A Elhayes, PhD · +20 1030000360
Always discuss trial participation with your own doctor first.
| Faculty of oral and dental medicine, cairo university | Giza, Giza Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07390851